Troy Davis - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Troy Davis's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Troy Davis
Verified
Writer, DM News
Beats
Cybersecurity , Immigration, Climate change, Privacy Rights , Law, Women’s Rights , Terrorism, Business And Public Policy , Voting Rights , Terrorism, Redistricting , Gerrymandering
Content
By Sheshtyn Paola Verified, Mioko Akiko, Shannon Mullen Verified, Troy Davis| Australian Journal of Pharmacy Verified Promethazine hydrochloride should not be given to children under six, warns TGA following investigations The Product Information (PI) for Phenergan will soon change to extend a contraindication from children less than two years to children less than six years of age, with an amendment to dosing as a result. Sanofi-Aventis Healthcare requested the latest updatesThis content is restricted to registered users only.
By Sheshtyn Paola Verified, Mioko Akiko, Shannon Mullen Verified, Troy Davis| Australian Journal of Pharmacy Verified Molnupiravir accounts for largest share of Covid-19 oral antiviral market, government expenditure: drug utilisation committee Molnupiravir (Lagevrio) is the most popular Covid-19 antiviral of choice, according to new data published on Friday. It also accounted for the highest government expenditure on medicines in 2022-23. In 2022, 448,358 patients were supplied 466,598 molnupiravir prescriptions, the DrugThis content is restricted to registered users only.
By Sheshtyn Paola Verified, Mioko Akiko, Shannon Mullen Verified, Troy Davis| Australian Journal of Pharmacy Verified Promethazine hydrochloride should not be given to children under six, warns TGA following investigations The Product Information (PI) for Phenergan will soon change to extend a contraindication from children less than two years to children less than six years of age, with an amendment to dosing as a result. Sanofi-Aventis Healthcare requested the latest updatesThis content is restricted to registered users only.
Company Info
DM News
DMN (DMNews) is a New York-based media company that specializes in direct, digital, and data-driven marketing insights. With over 30 years of experience, it provides industry analysis, research, and content tailored for senior marketers. The company offers a robust online platform and a monthly print magazine, delivering articles, features, and in-depth interviews with industry leaders. DMNews.com features daily content on marketing trends, technology, and campaigns, including a section called *The Work*, which highlights diverse marketing efforts. The company collaborates with industry veterans and journalists to provide expert analysis on topics such as behavioral targeting and privacy issues. DMN's audience includes senior marketers and CMOs looking for strategic insights to navigate the evolving marketing landscape. Recently, DMN revamped its website and print edition to enhance engagement, focusing on dynamic content that addresses current marketing challenges and trends. Its commitment to thought leadership and high-quality reporting makes it a valuable resource for marketing professionals.
'+1 646-638-6000
Founded: 1979